Omnicare (OCR) 76.89 $OCR
20.9% Return Seen to Date on SmarTrend Omnicare Call (OCR)
Comtex SmarTrend(R) - Fri Feb 13, 11:04AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 4 months, Omnicare has returned 20.92% as of today's recent price of $77.21.
OCR: 76.89 (+0.14)
Short Interest Expands By 11.8% For OCR
MarketNewsVideo.com - Thu Feb 12, 8:59AM CST
The most recent short interest data has been released by the NASDAQ for the 01/30/2015 settlement date, which shows a 794,012 share increase in total short interest for Omnicare Inc. , to 7,503,908, an increase of 11.83% since 01/15/2015.
OCR: 76.89 (+0.14)
Barbarian At The Gate: Omnicare (OCR)
at The Street - Tue Feb 10, 11:50AM CST
Trade-Ideas LLC identified Omnicare (OCR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
OCR: 76.89 (+0.14)
Gentherm Names Erin Ascher Vice President-Talent Development, Chief Human Resources Officer
PR Newswire - Tue Feb 10, 5:00AM CST
Gentherm (NASDAQ-GS: THRM), the global market leader and developer of innovative thermal management technologies, today announced that veteran global human resources executive Erin Ascher has been named Vice President-Talent Development and Chief Human Resources Officer, a newly-created position that reports directly to President and CEO Daniel R. Coker. Ascher joined Gentherm on February 5.
OCR: 76.89 (+0.14), THRM: 41.21 (+0.38)
ACS, Part of the Omnicare Specialty Care Group, to Provide Specialty Pharmacy Services for IBRANCE(R) (palbociclib)
Thomson Reuters ONE - Fri Feb 06, 6:45AM CST
CINCINNATI, February 6, 2015 - Advanced Care Scripts (ACS), a leading specialty pharmacy platform of Omnicare Specialty Care Group (SCG), announced today that they have been selected as a specialty pharmacy authorized to dispense Pfizer's Ibrance(R) (palbociclib).
OCR: 76.89 (+0.14)
5 Top Stocks With Soaring Dividend Growth
Todd Campbell, The Motley Fool - Motley Fool - Sun Feb 01, 7:03AM CST
Source: Flickr user taxcredits It has been shown that dividend-paying stocks outperform their nondividend-paying peers, but not all dividend stocks are created equal. Some dividend-paying companies are navigating sliding sales that could...
OCR: 76.89 (+0.14), UNH: 109.44 (-0.40), SHPG: 239.82 (+6.11), STJ: 67.48 (+0.65), ABBV: 58.05 (+1.00), AET: 96.12 (-0.96)
Uptrend Call Working As Omnicare Stock Rises 19.6% (OCR)
Comtex SmarTrend(R) - Fri Jan 30, 9:20AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 19.62% as of today's recent price of $76.38.
OCR: 76.89 (+0.14)
Shares of OCR Up 20.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 22, 4:48PM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 20.11% as of today's recent price of $76.69.
OCR: 76.89 (+0.14)
Omnicare to Report Fourth-Quarter and Year-End 2014 Financial Results and Hold Conference Call on Wednesday, February 25, 2015
Thomson Reuters ONE - Thu Jan 22, 6:45AM CST
CINCINNATI, January 22, 2015 - Omnicare, Inc. (NYSE:OCR) will release its financial results for the fourth-quarter and full-year 2014, before the market opens on Wednesday, February 25, 2015.
OCR: 76.89 (+0.14)
Stoltenberg Consulting Appoints Randy Carpenter Senior Vice President of Strategic Services
PR Newswire - Tue Jan 20, 8:05AM CST
Stoltenberg Consulting, Inc., a leading healthcare information technology consulting firm, announced today the appointment of Randy Carpenter as senior vice president of strategic services. In this executive leadership role, Carpenter will focus on strategic relationships with key healthcare and technology service providers, as well as on working with clients in the strategic planning, IT governance, interim management, mentoring and system selection, implementation and optimization areas.
OCR: 76.89 (+0.14)
Omnicare Up 15.9% Since SmarTrend Uptrend Call (OCR)
Comtex SmarTrend(R) - Thu Jan 15, 10:04AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 15.88% as of today's recent price of $73.99.
OCR: 76.89 (+0.14)
Long-term Care Software (EHR, eMAR, Payroll Management) Market - Global Forecast to 2019
M2 - Wed Jan 14, 3:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/5lqrw9/longterm_care) has announced the addition of the "Long-term Care Software Market by Product, Mode of Delivery & End User - Global Forecast to 2019" report to their offering. The global long-term care software market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $7,561.9 million by 2019 The factors such as rise in aging population that triggers the demand for healthcare IT solutions in LTC facilities, dearth of skilled nursing personnel, and increasing healthcare reforms and government initiatives across the globe are expected to spur the demand for LTC software. Similarly, opportunities offered by remote patient monitoring systems and cloud-based software are expected to boost the demand for LTC software. However, the unwillingness of traditional LTC providers to adopt software and high maintenance costs associated with software are hampering the growth of this market. Moreover, the lack of awareness and inadequate government initiatives in developing countries, resulting in lower adoption of LTC software, poses a challenge to this market. The long-term care software market, by product, is segmented into clinical solutions and non-clinical solutions. The clinical solutions segment is divided into EMR/EHR, e-prescribing, electronic medication administration records, medication management, and clinical decision support systems. The non-clinical solutions segment is further segmented into real-time location systems, remote patient monitoring systems, remote training and supervision systems, payroll management, talent management software and billing, invoicing and scheduling software. The market, by mode of delivery, includes on-premise, web-based, and cloud-based software. The major end users of long-term care software in this report are home health agencies, nursing homes and assisted living facilities, and hospice facilities. The report provides regionwise information on this market as well, split across major regionsNorth America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. By 2019, North America will continue to dominate and drive the long-term care software market, primarily due to the increasing demand for LTC software and the rise in aging population. On the other hand, the Asia-Pacific region is expected to witness significant growth during the forecast period, with the majority of growth primarily driven by changing population demographics and the economic development of regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Long-Term Care Software Market, By Product 8 Long-Term Care Software Market, By Mode Of Delivery 9 Long-Term Care Software Market, By End-User 10 Long-Term Care Software Market, By Geography 11 Competitive Landscape 12 Company Profiles - Allscripts Healthcare Solutions, Inc. - Aod Software (Advanced Answers On Demand, Inc.) - Cerner Corporation - Healthmedx - Kronos Incorporated - Matrix Care - Mckesson Corporation - Omnicare, Inc. - Omnicell, Inc. - Optimus Emr - Pointclickcare - Sigmacare For more information visit http://www.researchandmarkets.com/research/5l...gterm_care
OCR: 76.89 (+0.14), MDRX: 11.80 (+0.04), OMCL: 35.29 (+0.03), CERN: 70.98 (+1.15)
Crowell & Moring Expands Government Affairs And Health Care Groups With Seasoned Bi-Partisan Lobbying Team
PR Newswire - Mon Jan 12, 12:47PM CST
Crowell & Moring LLP is pleased to announce the arrival of James G. Flood as a partner and W. Scott Douglas as a senior policy director to the firm's Government Affairs and Health Care groups. With strong government relations and legal experience, Flood is a former counsel to Senator Charles E. Schumer (D-NY) and will chair Crowell & Moring's Government Affairs Group, and Douglas is the former finance director for Senate Majority Leader Mitch McConnell (R-KY). The bi-partisan duo joins the firm from Omnicare, Inc., where Flood served as vice president, government affairs, and Douglas served as senior director, government affairs.
OCR: 76.89 (+0.14)
Omnicare Announces Conversion Rate Adjustment for Convertible Debentures; Series A and Series B Trust PIERS to Accrue Contingent Interest
Thomson Reuters ONE - Fri Jan 09, 4:30PM CST
CINCINNATI, January 9, 2015 - Omnicare, Inc. (NYSE: OCR) (the "Company"
announced today an adjustment to the conversion rate of its 3.25% Convertible Senior Debentures due 2035 and its 3.25% Convertible Senior Exchange Debentures due 2035 (collectively, the "2035 Debentures" . Effective December 17, 2014, the adjusted conversion rate for the 2035 Debentures is 12.9869 shares of common stock per $1,000 principal amount, or approximately $77.00 per share.
OCR: 76.89 (+0.14)
Omnicare Shares Up 17.9% Since SmarTrend's Buy Recommendation (OCR)
Comtex SmarTrend(R) - Thu Jan 08, 9:59AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 17.95% as of today's recent price of $75.31.
OCR: 76.89 (+0.14)
Upgrade Alert for Omnicare (OCR)
Comtex SmarTrend(R) - Thu Jan 08, 7:02AM CST
Omnicare (NYSE:OCR) was upgraded from Equal Weight to Overweight at Barclays Capital today. The stock closed yesterday at $73.51 on volume of 525,000 shares, below average daily volume of 956,000. Omnicare has overhead space with shares priced $73.52, or 0.3% below the average consensus analyst price target of $73.78. Omnicare shares have support at the 50-day moving average (MA) of $70.34 and additional support at the 200-day MA of $64.57.
OCR: 76.89 (+0.14)
Omnicare to Present at the J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Tue Jan 06, 7:00AM CST
CINCINNATI, January 6, 2015 - Omnicare, Inc. (NYSE:OCR) today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 2:00 p.m. PST (5:00 p.m. EST) in San Francisco, California.
OCR: 76.89 (+0.14), JPM: 59.67 (+0.10)
PharMerica Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
On Jan 2, 2015, Zacks Investment Research upgraded PharMerica Corp. (PMC) to a Zacks Rank #1 (Strong Buy)
PMC: 24.40 (-0.18), OCR: 76.89 (+0.14), AFAM: 30.88 (+0.37)
Dividend Champions For January 2015
David Fish - at Seeking Alpha - Thu Jan 01, 3:24AM CST
SJR: 23.92 (+0.13), GE: 25.15 (+0.26), OCR: 76.89 (+0.14), WILN: 2.71 (-0.01), DEI: 29.24 (-0.20), BLX: 31.77 (+0.51), THG: 72.27 (-0.55), VTR: 76.61 (-0.41), TEL: 70.76 (+0.38), WDR: 49.94 (+0.15), BCS: 15.77 (+0.12), BUD: 121.72 (-0.80), BMR: 22.85 (-0.13), EMN: 75.67 (+0.56), ARE: 94.90 (-1.29), WU: 19.02 (+0.71), PRA: 45.58 (-0.52), GIL: 59.48 (+0.23), PFE: 34.64 (-0.23), CUBE: 24.28 (-0.32), AHT: 10.63 (-0.04), DIS: 104.17 (+0.59), AMGN: 153.48 (+0.30), HBNC: 23.16 (+0.16), COR: 48.08 (+1.08), GLW: 25.00 (+0.14), MORN: 78.24 (+2.16), ERIE: 90.87 (-0.18), PSEC: 8.67 (+0.07), MAA: 73.82 (-0.59)
20.9% Return Seen to Date on SmarTrend Omnicare Call (OCR)
Comtex SmarTrend(R) - Fri Feb 13, 11:04AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 4 months, Omnicare has returned 20.92% as of today's recent price of $77.21.
OCR: 76.89 (+0.14)
Short Interest Expands By 11.8% For OCR
MarketNewsVideo.com - Thu Feb 12, 8:59AM CST
The most recent short interest data has been released by the NASDAQ for the 01/30/2015 settlement date, which shows a 794,012 share increase in total short interest for Omnicare Inc. , to 7,503,908, an increase of 11.83% since 01/15/2015.
OCR: 76.89 (+0.14)
Barbarian At The Gate: Omnicare (OCR)
at The Street - Tue Feb 10, 11:50AM CST
Trade-Ideas LLC identified Omnicare (OCR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
OCR: 76.89 (+0.14)
Gentherm Names Erin Ascher Vice President-Talent Development, Chief Human Resources Officer
PR Newswire - Tue Feb 10, 5:00AM CST
Gentherm (NASDAQ-GS: THRM), the global market leader and developer of innovative thermal management technologies, today announced that veteran global human resources executive Erin Ascher has been named Vice President-Talent Development and Chief Human Resources Officer, a newly-created position that reports directly to President and CEO Daniel R. Coker. Ascher joined Gentherm on February 5.
OCR: 76.89 (+0.14), THRM: 41.21 (+0.38)
ACS, Part of the Omnicare Specialty Care Group, to Provide Specialty Pharmacy Services for IBRANCE(R) (palbociclib)
Thomson Reuters ONE - Fri Feb 06, 6:45AM CST
CINCINNATI, February 6, 2015 - Advanced Care Scripts (ACS), a leading specialty pharmacy platform of Omnicare Specialty Care Group (SCG), announced today that they have been selected as a specialty pharmacy authorized to dispense Pfizer's Ibrance(R) (palbociclib).
OCR: 76.89 (+0.14)
5 Top Stocks With Soaring Dividend Growth
Todd Campbell, The Motley Fool - Motley Fool - Sun Feb 01, 7:03AM CST
Source: Flickr user taxcredits It has been shown that dividend-paying stocks outperform their nondividend-paying peers, but not all dividend stocks are created equal. Some dividend-paying companies are navigating sliding sales that could...
OCR: 76.89 (+0.14), UNH: 109.44 (-0.40), SHPG: 239.82 (+6.11), STJ: 67.48 (+0.65), ABBV: 58.05 (+1.00), AET: 96.12 (-0.96)
Uptrend Call Working As Omnicare Stock Rises 19.6% (OCR)
Comtex SmarTrend(R) - Fri Jan 30, 9:20AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 19.62% as of today's recent price of $76.38.
OCR: 76.89 (+0.14)
Shares of OCR Up 20.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 22, 4:48PM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 20.11% as of today's recent price of $76.69.
OCR: 76.89 (+0.14)
Omnicare to Report Fourth-Quarter and Year-End 2014 Financial Results and Hold Conference Call on Wednesday, February 25, 2015
Thomson Reuters ONE - Thu Jan 22, 6:45AM CST
CINCINNATI, January 22, 2015 - Omnicare, Inc. (NYSE:OCR) will release its financial results for the fourth-quarter and full-year 2014, before the market opens on Wednesday, February 25, 2015.
OCR: 76.89 (+0.14)
Stoltenberg Consulting Appoints Randy Carpenter Senior Vice President of Strategic Services
PR Newswire - Tue Jan 20, 8:05AM CST
Stoltenberg Consulting, Inc., a leading healthcare information technology consulting firm, announced today the appointment of Randy Carpenter as senior vice president of strategic services. In this executive leadership role, Carpenter will focus on strategic relationships with key healthcare and technology service providers, as well as on working with clients in the strategic planning, IT governance, interim management, mentoring and system selection, implementation and optimization areas.
OCR: 76.89 (+0.14)
Omnicare Up 15.9% Since SmarTrend Uptrend Call (OCR)
Comtex SmarTrend(R) - Thu Jan 15, 10:04AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 15.88% as of today's recent price of $73.99.
OCR: 76.89 (+0.14)
Long-term Care Software (EHR, eMAR, Payroll Management) Market - Global Forecast to 2019
M2 - Wed Jan 14, 3:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/5lqrw9/longterm_care) has announced the addition of the "Long-term Care Software Market by Product, Mode of Delivery & End User - Global Forecast to 2019" report to their offering. The global long-term care software market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $7,561.9 million by 2019 The factors such as rise in aging population that triggers the demand for healthcare IT solutions in LTC facilities, dearth of skilled nursing personnel, and increasing healthcare reforms and government initiatives across the globe are expected to spur the demand for LTC software. Similarly, opportunities offered by remote patient monitoring systems and cloud-based software are expected to boost the demand for LTC software. However, the unwillingness of traditional LTC providers to adopt software and high maintenance costs associated with software are hampering the growth of this market. Moreover, the lack of awareness and inadequate government initiatives in developing countries, resulting in lower adoption of LTC software, poses a challenge to this market. The long-term care software market, by product, is segmented into clinical solutions and non-clinical solutions. The clinical solutions segment is divided into EMR/EHR, e-prescribing, electronic medication administration records, medication management, and clinical decision support systems. The non-clinical solutions segment is further segmented into real-time location systems, remote patient monitoring systems, remote training and supervision systems, payroll management, talent management software and billing, invoicing and scheduling software. The market, by mode of delivery, includes on-premise, web-based, and cloud-based software. The major end users of long-term care software in this report are home health agencies, nursing homes and assisted living facilities, and hospice facilities. The report provides regionwise information on this market as well, split across major regionsNorth America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. By 2019, North America will continue to dominate and drive the long-term care software market, primarily due to the increasing demand for LTC software and the rise in aging population. On the other hand, the Asia-Pacific region is expected to witness significant growth during the forecast period, with the majority of growth primarily driven by changing population demographics and the economic development of regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Long-Term Care Software Market, By Product 8 Long-Term Care Software Market, By Mode Of Delivery 9 Long-Term Care Software Market, By End-User 10 Long-Term Care Software Market, By Geography 11 Competitive Landscape 12 Company Profiles - Allscripts Healthcare Solutions, Inc. - Aod Software (Advanced Answers On Demand, Inc.) - Cerner Corporation - Healthmedx - Kronos Incorporated - Matrix Care - Mckesson Corporation - Omnicare, Inc. - Omnicell, Inc. - Optimus Emr - Pointclickcare - Sigmacare For more information visit http://www.researchandmarkets.com/research/5l...gterm_care
OCR: 76.89 (+0.14), MDRX: 11.80 (+0.04), OMCL: 35.29 (+0.03), CERN: 70.98 (+1.15)
Crowell & Moring Expands Government Affairs And Health Care Groups With Seasoned Bi-Partisan Lobbying Team
PR Newswire - Mon Jan 12, 12:47PM CST
Crowell & Moring LLP is pleased to announce the arrival of James G. Flood as a partner and W. Scott Douglas as a senior policy director to the firm's Government Affairs and Health Care groups. With strong government relations and legal experience, Flood is a former counsel to Senator Charles E. Schumer (D-NY) and will chair Crowell & Moring's Government Affairs Group, and Douglas is the former finance director for Senate Majority Leader Mitch McConnell (R-KY). The bi-partisan duo joins the firm from Omnicare, Inc., where Flood served as vice president, government affairs, and Douglas served as senior director, government affairs.
OCR: 76.89 (+0.14)
Omnicare Announces Conversion Rate Adjustment for Convertible Debentures; Series A and Series B Trust PIERS to Accrue Contingent Interest
Thomson Reuters ONE - Fri Jan 09, 4:30PM CST
CINCINNATI, January 9, 2015 - Omnicare, Inc. (NYSE: OCR) (the "Company"
announced today an adjustment to the conversion rate of its 3.25% Convertible Senior Debentures due 2035 and its 3.25% Convertible Senior Exchange Debentures due 2035 (collectively, the "2035 Debentures" . Effective December 17, 2014, the adjusted conversion rate for the 2035 Debentures is 12.9869 shares of common stock per $1,000 principal amount, or approximately $77.00 per share. OCR: 76.89 (+0.14)
Omnicare Shares Up 17.9% Since SmarTrend's Buy Recommendation (OCR)
Comtex SmarTrend(R) - Thu Jan 08, 9:59AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 3 months, Omnicare has returned 17.95% as of today's recent price of $75.31.
OCR: 76.89 (+0.14)
Upgrade Alert for Omnicare (OCR)
Comtex SmarTrend(R) - Thu Jan 08, 7:02AM CST
Omnicare (NYSE:OCR) was upgraded from Equal Weight to Overweight at Barclays Capital today. The stock closed yesterday at $73.51 on volume of 525,000 shares, below average daily volume of 956,000. Omnicare has overhead space with shares priced $73.52, or 0.3% below the average consensus analyst price target of $73.78. Omnicare shares have support at the 50-day moving average (MA) of $70.34 and additional support at the 200-day MA of $64.57.
OCR: 76.89 (+0.14)
Omnicare to Present at the J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Tue Jan 06, 7:00AM CST
CINCINNATI, January 6, 2015 - Omnicare, Inc. (NYSE:OCR) today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 2:00 p.m. PST (5:00 p.m. EST) in San Francisco, California.
OCR: 76.89 (+0.14), JPM: 59.67 (+0.10)
PharMerica Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
On Jan 2, 2015, Zacks Investment Research upgraded PharMerica Corp. (PMC) to a Zacks Rank #1 (Strong Buy)
PMC: 24.40 (-0.18), OCR: 76.89 (+0.14), AFAM: 30.88 (+0.37)
Dividend Champions For January 2015
David Fish - at Seeking Alpha - Thu Jan 01, 3:24AM CST
SJR: 23.92 (+0.13), GE: 25.15 (+0.26), OCR: 76.89 (+0.14), WILN: 2.71 (-0.01), DEI: 29.24 (-0.20), BLX: 31.77 (+0.51), THG: 72.27 (-0.55), VTR: 76.61 (-0.41), TEL: 70.76 (+0.38), WDR: 49.94 (+0.15), BCS: 15.77 (+0.12), BUD: 121.72 (-0.80), BMR: 22.85 (-0.13), EMN: 75.67 (+0.56), ARE: 94.90 (-1.29), WU: 19.02 (+0.71), PRA: 45.58 (-0.52), GIL: 59.48 (+0.23), PFE: 34.64 (-0.23), CUBE: 24.28 (-0.32), AHT: 10.63 (-0.04), DIS: 104.17 (+0.59), AMGN: 153.48 (+0.30), HBNC: 23.16 (+0.16), COR: 48.08 (+1.08), GLW: 25.00 (+0.14), MORN: 78.24 (+2.16), ERIE: 90.87 (-0.18), PSEC: 8.67 (+0.07), MAA: 73.82 (-0.59)
